B3RDA4 AF NFT

Peptide chain release factor 3

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeic3w5gqrgu7wsxk2wx6cb2mogduu33zumbxzvh7syjdnjondu2pdq/metadata.json
IPFS of structure file: 
bafybeihu2gs64sfyoelvymyjianrr5dksyuly6gxzfswnvz2ibgj2mbuoi/AF-B3RDA4-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x86909E648E70f97B557114F43d121a6C1146e9A3
First NFT owner address (bech32): 
genesis1s6gfueywwruhk4t3zn6r6ys6dsg5d6drzh24vu
Current NFT ID #340701 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
340701
Accession (UniProt):
B3RDA4
Name::
Peptide chain release factor 3
Experimental Method:
Predicted structure
Sequence source:
Cupriavidus taiwanensis (strain DSM 17343 / BCRC 17206 / CCUG 44338 / CIP 107171 / LMG 19424 / R1)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B3RDA4 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B3RDA4|RF3_CUPTR Peptide chain release factor 3 OS=Cupriavidus taiwanensis (strain DSM 17343 / BCRC 17206 / CCUG 44338 / CIP 107171 / LMG 19424 / R1) OX=977880 GN=prfC PE=3 SV=1 MSSLVSEIARRRTFAIISHPDAGKTTLTEKLLWFGGAIQVAGEVRARKADRHATSDWMELEKQRGISVTSSVMQFPYSRESADGKAQENIVNLLDTPGHEDFSEDTYRTLTAVDSAVMVIDSVNGVEAQTIKLLNVCRLRDTPILTFINKLDREGRSPIELLDEIEDVLQIQCAPMTWPIGMGKAFRGVYHLIDDKVQLFDPHGDKGTAAILDGLDNPELDRILGSQAEELRIEIELVRGASHTFDKAAFLNGKQTPVYFGSAINNFGVQSLLDALCELSPPPLARNTESRVVEPQEPKFTGFVFKIQANMDPRHRDRIAFVRVCSGRFERGMKLLHVSAGKTVAINNAITFMAQDRNTTEEAYAGDIIGVPNHGTIRLGDVFTEGEPLKFTGIPSFAPEFFRRARLNNPLKVKQLQKGLQQLAEEGATQMFRPLASNDLVLGAVGILQFDVVAHRLEHEYGVDAIFESHECATARWLKGTPAEIEKLIAKAGHNVALDGAGDHVYLAPSMVNLRLTQERFPELQFLETREIV